334 related articles for article (PubMed ID: 18171248)
1. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?
Moore MR; Whitney CG
Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248
[No Abstract] [Full Text] [Related]
2. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
Jacobs MR; Good CE; Bajaksouzian S; Windau AR
Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
Beall B
Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
[No Abstract] [Full Text] [Related]
5. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
[TBL] [Abstract][Full Text] [Related]
6. Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities.
Mackenzie G; Carapetis J; Leach AJ; Hare K; Morris P
Vaccine; 2007 Mar; 25(13):2428-33. PubMed ID: 17030493
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
Toltzis P; Jacobs MR
Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
[TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.
Dias R; Caniça M
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):35-42. PubMed ID: 17854472
[TBL] [Abstract][Full Text] [Related]
9. Reduction of carriage and transmission of Streptococcus pneumoniae: the beneficial "side effect" of pneumococcal conjugate vaccine.
Azzari C; Resti M
Clin Infect Dis; 2008 Oct; 47(8):997-9. PubMed ID: 18781870
[No Abstract] [Full Text] [Related]
10. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Pletz MW; Maus U; Krug N; Welte T; Lode H
Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
[TBL] [Abstract][Full Text] [Related]
11. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
12. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine.
Obando I; Arroyo LA; Sánchez-Tatay D; Tarragó D; Moreno D; Hausdorff WP; Brueggemann AB
Clin Microbiol Infect; 2007 Mar; 13(3):347-8. PubMed ID: 17391398
[No Abstract] [Full Text] [Related]
14. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal colonization: a target for pneumococcal vaccination.
Käyhty H; Auranen K; Nohynek H; Dagan R; Mäkelä H
Expert Rev Vaccines; 2006 Oct; 5(5):651-67. PubMed ID: 17181439
[TBL] [Abstract][Full Text] [Related]
16. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
Moraga-Llop FA
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
[No Abstract] [Full Text] [Related]
17. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine.
McEllistrem MC; Adams J; Mason EO; Wald ER
J Infect Dis; 2003 Dec; 188(11):1679-84. PubMed ID: 14639539
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era.
Marsh RL; Smith-Vaughan H; Beissbarth J; Hare K; Kennedy M; Wigger C; Mellon G; Stubbs E; Gadil JR; Pettit A; Mackenzie G; Tipakalippa P; Morris PS; Leach AJ
Vaccine; 2007 Mar; 25(13):2434-6. PubMed ID: 17028080
[TBL] [Abstract][Full Text] [Related]
19. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.
Park SY; Moore MR; Bruden DL; Hyde TB; Reasonover AL; Harker-Jones M; Rudolph KM; Hurlburt DA; Parks DJ; Parkinson AJ; Schuchat A; Hennessy TW
Pediatr Infect Dis J; 2008 Apr; 27(4):335-40. PubMed ID: 18316986
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].
Blanco Quirós A; Giménez Sánchez F; Asensi Botet F; Bernaola Iturbe E; Martín Fde J; García Pérez J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V;
An Esp Pediatr; 2002 Oct; 57(4):287-9. PubMed ID: 12392660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
